Performance of MOTO Medial® Unicompartmental Knee Arthroplasty

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

269 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-09

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, multi-center study, designed to assess mid-term performance of the MOTO Medial® Unicompartmental Knee Arthroplasty (UKA), with patient report outcomes, clinical findings and radiographic analysis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bilateral Total Knee Arthroplasty vs Unicompartment Arthroplasty Retrospective and Clinical Outcome Study

NCT02583113

Osteoarthritis

WITHDRAWN

MOTO Post-marketing Surveillance Study

NCT04072055

Osteonecrosis Osteo Arthritis Knee

TERMINATED

Unicondylar Knee Arthroplasty Versus Total Knee Arthroplasty in Patients With Anteromedial Osteoarthritis of the Knee

NCT02430129

Osteoarthritis

COMPLETED NA

Isokinetic Performance After Cruciate-substituting Ultra-congruent and Posterior Stabilized Total Knee Arthroplasties

NCT04419311

Osteoarthritis, Knee Knee Arthritis

COMPLETED NA

Trial of Unicompartmental Versus Total Knee Arthroplasty

NCT03385759

Osteo Arthritis Knee

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, multi-center study, designed to assess mid-term performance of the MOTO Medial® UKA, with patient report outcomes, clinical findings and radiographic analysis. Additionally, several perioperative factors, medical and surgical history will be evaluated. Implant survival and complications will be detailed throughout the study. Data from pre-operative evaluation, day of surgery, and post-operatively at 4 weeks, 6 months, and years 1, 2 \& 5, will be collected.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis Knee Arthritis Knee Pain Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interventional : MOTO Medial® UKA

Interventional : Patients who are planned to undergo a primary medial UKA using the MOTO Medial® will be enrolled.

MOTO Medial® UKA

Intervention Type DEVICE

Knee replacement surgery with the MOTO Medial® UKA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MOTO Medial® UKA

Knee replacement surgery with the MOTO Medial® UKA

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Medial Unicondylar Knee Replacement

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be able to read, understand and provide written informed consent on the Institutional Review Board (IRB) approved Informed Consent Form (ICF).

* Ability to understand and provide written authorization for use and disclosure of personal health information.
* Subject who are able and willing to comply with the study protocol and follow-up visits.
* Must be 18 years or older to participate.
* Subjects must have medial knee disease in the affected knee compliant with the FDA-approved indications for use of MOTO Medial® UKA.
* Must have had no prior arthroplasty to the medial compartment of the study knee.
* Subjects must be able to return for the follow-up appointments, and have the mental capacity to cooperate and complete Patient Reported Outcome questionnaires, physical exam and radiographs.

Exclusion Criteria

* Knee ligament instability (deficiency of cruciate or collateral ligaments)

* Inflammatory Arthritis
* History of prior knee infection
* History of Alcoholism or Drug Abuse
* Currently on chemotherapy or radiation therapy for neoplastic disease. Medacta MOTO Medial® Version 1 Confidential Page 9 of 36 June 5, 2017
* Currently on immunosuppressive medications including steroids
* History of known sensitivity or allergy to materials used in orthopedic implants, specifically Titanium and Cobalt-Chrome alloys
* Habitual use of narcotic pain medications prior to surgery (more than 3 doses or pills per week)
* History of metabolic disorder affecting the skeletal system other than osteoarthritis or osteoporosis (e.g., Osteomalacia, Ricketts)
* History of chronic pain issues for reasons other than knee pain.
* Women who are pregnant.
* Psychiatric illness
* Any patient, in the opinion of the investigator, is unable to fully comply with the surgical, rehabilitation, or follow-up aspects of this procedure.
* Prior joint arthroplasty on the target knee, including prior medial UKA (revision), lateral UKA, or Patellofemoral Joint
* Prior high tibial osteotomy (HTO).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes